Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2007 Nov 21.
Published in final edited form as: Carbohydr Res. 2007 Jun 13;342(12-13):1624–1635. doi: 10.1016/j.carres.2007.06.012

Synthesis and conformational behavior of the difluoromethylene linked C-glycoside analog of β-galactopyranosyl-(1↔1)-α-mannopyranoside

Richard W Denton 1,a, Kurissery A Tony 1,a, José Juan Hernández-Gay 1,b, F Javier Cañada 1,b, Jesús Jiménez-Barbero 1,b, David R Mootoo 1,a
PMCID: PMC2084073  NIHMSID: NIHMS28333  PMID: 17601514

Abstract

Exact C-glycosides in which the glycosidic oxygen of an O-glycoside is replaced with a methylene group have been advertised as hydrolytically stable mimetics of their parent O-glycosides. While this substitution assures greater stability, the lower polarity and increased conformational flexibility in the intersaccharide linker brought about by this change may compromise biological mimicry. In this regard, C-glycosides in which the pseudoanomeric methylene is replaced with a difluoromethylene group are interesting because the CF2 group is more of an isopolar replacement for oxygen than a CH2. In addition, the CF2 residue is expected to instill conformational bias into the intersaccharide torsions. Herein is described the synthesis and conformational behavior of the difluoromethylene linked C-glycoside of β-d-galactopyranosyl-(1↔1)-α-d-mannopyranoside. The synthesis centers on the formation of the galactose residue via an oxocarbenium ion-enol ether cyclization. Conformational analysis, using a combination of molecular mechanics, dynamics and NMR spectroscopy. suggests that the difluoro-C-glycoside populates the non-exo-Gal/exo-Man conformer to a major extent (ca 50%), with a minor contribution (∼15%) from the exo-Gal/exo-Man conformer that corresponds to the ground sate of the parent O-glycoside.

1. Introduction

The replacement of the glycosidic oxygen in an O-glycoside with a methylene substituent leads to an analogue with greater hydrolytic stability than the parent O-glycoside.1 Such compounds may function as biological mimetics of their parent O-glycosides but the extent of this mimicry could be compromised by the lower polarity and greater flexibility of such C-glycosides about the intersaccharide torsions.2,3,4,5 In this vein, we have been interested in the mimicry of C-glycosides in which the methylene linker is replaced with a CHF or CF2 residue. The design of these mimetics was guided by two tenets. First, the electronegativity of the fluorine substituents could make the intersaccharide linker more isopolar to the glycosidic oxygen.6 Second, based on the unusual conformational properties of 2-fluoroethanols and related structures, such fluoro-C-glycosides are expected to have a more well defined conformational bias than the exact C-glycoside with respect to the intersaccharide linker, such that they may more closely mimic the conformational properties of the O-glycoside.7,8 Indeed, the use of CHF and CF2 as isosteres of oxygen has been examined in other molecules of biological interest, and examples of CF2 linked C-furanosides have been prepared.9,10,11 We have previously reported the synthesis and conformational behavior of 2, 3 and 4,12,13 the exact and the CHF linked analogues of 1, a known O-disaccharide mimetic of sialyl Lewis X (Figure 1).14 In this series the fluoro-C-glycoside 3 was found to be the closest conformational mimic of 1. Herein, as an extension of this study, we describe the synthesis and conformational properties of the CF2 linked analogue 5.15

Figure 1.

Figure 1

O- and C-disaccharides

2. Results and Discussion

2.1 Synthesis

We have been developing a de novo synthesis of complex C-disaccharides 10, in which the key step is the formation of a C1 substituted glycal 9 via an enol ether–oxocarbenium ion cyclization.16 The C-glycoside 10 is then obtained by the stereoselective hydroboration of 9. Because this method was previously successful for hydroxymethyl linked C-glycosides (e.g., 10: X/Y = H/OH), our initial approach to 5 was based on fluorination of the ketone derived from 10.17 Not surprisingly, given the highly substituted nature of this precursor, this strategy was unsuccessful. Therefore, a revised plan in which the CF2 group was introduced in a less complex precursor (i.e., 7: X/Y = F/F) was adopted. A key question with this approach was the feasibility of the oxocarbenium ion cyclization on the difluorinated enol ether thioacetal (i.e., 8, X/Y = F/F) in light of the noted deactivation of related difluorinated enol ethers to electrophilic reagents.18 In addition, while the thioacetal precursor 5 was available from earlier investigations, a synthesis of an α,α-difluoroacid like 7 had to be devised.

Initial attempts at the synthesis of the α,α-difluoroacid through treatment an α-ketoester precursor with DAST17 led to intractable mixture of products. A successful plan originated in the reaction of the Reformatsky-like reagent from methyl bromodifluoroacetate and the known aldehyde 11 (Scheme 2).19,20 This led to an inseparable mixture of epimeric alcohols (R)- and (S)- 12 in an approximate 1:3 ratio. Acetylation of the mixture allowed separation of the acetates, which were individually treated with sodium methoxide in methanol to give (R)- and (S)- 13, the respective methyl ester derivatives of (R)- and (S)- 12. The configuration at the newly formed stereogenic center in these products was tentatively assigned by NMR comparison with closely related diastereomeric pairs19 and the stereochemistry of the desired isomer (S)-12 eventually confirmed in the tetrahydropyran derivatives 20 and 21 (vide infra). Alkene (S)-13 was treated with m-CPBA and the resulting 2:1 mixture of epoxides exposed to sodium methoxide in methanol to give a product that exhibited partial ester hydrolysis. The crude material was therefore treated with TMS-diazomethane, following which chromatography afforded two fractions in an approximate ratio of 5:2, an unseparated mixture of two isomeric tetrahydropyrans 15 and another component that was presumed to be a seven-membered ring isomer 16. Silylation of the mixture of primary alcohols 15 gave 17, the C-pyranoside with an “α-d-manno” configuration and the “β-l-gulo” isomer 19 in a 3:2 ratio. The stereochemistry of 17 and 19 was assigned by 1H NMR analysis of the acetylated derivatives 20 and 21. Thus, the J values for the ring protons of 20 and the appearance of an NOE between H1 and H4 suggested a distorted chair-like conformation. This translates to syn relationships between H1 and H4 and H2 and H3, and confirms the configuration at C1 and C2, the two new stereogenic centers that were introduced in the reaction leading to (S)-12. Similarly, J data and an NOE between H1 and H5 pointed to the stereochemistry indicated in 21. That the configuration at C1 in 20 and 21 was determined to be opposite is consistent with synthetic logic. Finally, saponification of 17 provided 18, the required precursor for C-disaccharide 5.

Scheme 2.

Scheme 2

Synthesis of difluoroacid 18

Thioacetal 6 and difluoro acid 18 were next subjected to the C-glycosidation sequence (Scheme 3). The Yamaguchi esterification procedure on 6 and 18 provided ester 22 in 76% yield.21 Takai methylenation on 22 afforded the difluoro enol ether 23 in 63% yield based on recovered 22.22 The reactivity of the difluoro ester and enol ether under acidic and basic conditions is noteworthy. Thus, the acid sensitivity of the methylene linked enol ethers that were prepared in our earlier study called for chromatography on basic alumina.16 While the difluoro derivative 23 was also stable under these conditions, it was discovered during the purification of the mixture of 22 and 23, that the α,α-difluoro ester was not. In comparison, both ester 22 and enol ether 23 were stable to chromatography on silica gel. The key cyclization reaction on 23 was promoted by methyl triflate in the presence of 2,6-di-tert-butyl-4-methylpyridine (DTBMP), giving the difluoromethylene linked glycal 24 in 82% yield. Thus, as initially feared, the difluoromethylene moiety did not have an adverse effect on the oxocarbenium ion cyclization. Hydroboration of 24 provided the difluoromethylene linked C-disaccharide 25 as a single diastereomer in 86% yield. The straightforward removal of the alcohol protecting groups provided the title C-disaccharide 5.

Scheme 3.

Scheme 3

Synthesis of difluoro-C-disaccharide 5.

2.2 Conformational analysis

The potential energy surfaces for 5 was calculated using the MM3*23 force field, as previously described (Figure 2).12,24,25

Figure 2.

Figure 2

Steric energy map (ΦMan, ΦGal) calculated by MM3* with ε = 80 for 5. Contours are given every 2.5 kJ mol−1

These maps are useful to delimit the low-energy regions that are accessible to rotation around the glycosidic torsion angles ΦGal (H1Gal–C1Gal–X–C1Man) and ΦMan (H1Man–C1Man–X–C1Gal). The different conformers have been dubbed, exo, non-exo and anti with respect to glyconic torsions ΦGal and ΦMan, by analogy with the exo-anomeric notation for O-glycosides. Thus exoΦGal and exoΦMan correspond to values of ca +60° and −60°, non exoΦGal and nonexoΦMan to −60° and +60°, and antiΦGal and antiΦMan to 180° respectively. Four principal low-energy conformer types were obtained, but with very different populations: (A) exo-ΦGal/non-exo-ΦMan, (B) exo-ΦGal/exo-ΦMan, (C) non-exo-ΦGal/exo-ΦMan, and (D) anti-ΦGal/non-exo-ΦMan. These conformations are shown in Figure 3, and their geometries and relative energies summarized in Table 1.

Figure 3.

Figure 3

Stereoviews of the global and local minima A–D of 5 according to MM3* calculations. See Table 1 for ΦGal and ΦMan for the different conformers.

Table 1.

Comparison between the inter-residue proton–proton distances calculated by MM3* for the conformers A–D (approximated ΦGal and ΦMan angles in brackets), of 5 and the observed NOEs in the 1D-NOESY spectrum at 350 ms mixing time for 5. In all cases, NOEs or ROEs were positive; i.e., the cross peaks showed different sign to diagonal peaks, as expected for small molecules. Relative steric energies for (ΔE, kJ mol) are also given. Interproton distances corresponding to exclusive NOEs are shown in bold.

Conformer
(FGal/FMan)
A(60/60)
exo/non exo
B(50/−50)
exo/exo
C(−70/−70)
non exo/
exo
D(−170/60)
anti/non
exo
Ensemble
Average
Best fit
A:B:C:D
?E (kJ/mol) 2.0 1.6 0 12.8
Population (%) 22.5% 26.5% 50.7% 0,3% 25:15:50:10
NOE exp (%)/
distance (Å)
calc
distance
(Å)
calc
distance
(Å)
calc
distance
(Å)
calc
distance
(Å)
Ensemble
Average
Distance
(Å)
1M-2M
(Internal
reference)
4.7%/2.55 (Å) 2.55 2.55 2.55 2.55
1G-1M 1.9%/3.0 (Å) 3.0 2.4 3.2 3.7 2.8 2.9
1G-2M 3.9%/2.6 (Å) 2.1 4.3 4.7 3.8 2.7 2.6
1G-5M Overlap 4.5 4.2 2.5 4.5 - -
1M-2G 1.7 %/3.0 (Å) 4.3 4.7 3.2 2.2 3.5 3.0
2M-G2 <0.4 %/>3.8 (Å) 4.9 5.2 4.8 2.7 4.8 3.8

In addition, the conformational stability of the different conformers was checked by using MD simulations also with the MM3* force field.26 Some of the computed ΦMan/ΦGal distributions are displayed in Figure 4.

Figure 4.

Figure 4

Frequency of sampling of ΦMan/ΦGal torsion angles from the MD simulations (MM3*) for 5, starting from the different local minima. From left to right, starting from minima A, B, and C, respectively. Transitions from B to A (central panel) and from C to B (right panel) are observed.

Examination of the four different conformational families revealed several proton-proton distances of close to 2.5 212B; that are unique to a particular conformation of 5. An NOE corresponding to any of these proton pairs is deemed an exclusive NOE, and is diagnostic of a specific conformation.27 Exclusive NOEs are shown in bold in Table 1.

2.3 Experimental confirmation of modeling data by NMR

In order to deduce the final conformational distribution for 5, the predictions from the force field calculations were compared with the experimental data as determined from NMR. The chemical shifts in D2O are listed in Table 2. Assignment of resonances was made through a combination of COSY, TOCSY, 1D and 2D-NOESY/ROESY, and HSQC experiments.

Table 2.

1H NMR chemical shifts (δ, ppm) and vicinal coupling constants (J, Hz) for compound 5.

atom δ, ppm (J, Hz)
H1M 4.51 (2.3, 14.3, 19.4)
H2M 4.33 (2.3, 3.4)
H3M 3.92 (3.8, 9.1)
H4M 3.62 (9.0, 9.0)
H5M 3.66 (9.0, 2.2, not meas.)
H6aM 3.89 (12.2)
H6bM 3.74
F1 (14.3, 14.3)
F2 (14.3, 19.4)
H1G 3.84 (14.3, 14.3, 10.0)
H2G 3.93 (9.8, 9.6)
H3G 3.70 (9.6, 3.4)
H4G 4.00 (3.4, 0.5)
H5G 3.79 (0.5, 3.5, 6.8)
H6aG 3.76
H6bG 3.74 (6.8, 12.2)

The J values for the ring protons indicate that all the pyranose chairs adopt the usual 4C1 chair, (Table 2). The intermediate observed values for the C5–C6 lateral chains are in agreement with equilibria between the tg:gt conformers for the Gal ring and the gg:gt conformers for the Man moiety.28 The anomeric protons of both Gal and Man residues show scalar couplings to the fluorine atoms at the pseudoglycosidic linkage. The observed couplings vary between only 15 and 20 Hz, which are intermediate values for vicinal H/F arrangements. In previous studies, we have used the vicinal H/F couplings as additional data to assess the conformational equilibrium around the intersaccharide torsions.13 Unfortunately, it is well known that the presence of additional electronegative substituents along the coupling pathway strongly modify the relationship between torsion angles and coupling constants and, thus the available Karplus-like equation for vicinal H/F couplings is not valid for this molecule. Therefore, the conformational analysis with respect to the intersaccharide linker has to rely exclusively on the NOE data.29,30 Accordingly, NOESY and ROESY experiments were carried out to determine the intensities of the observed NOEs. Experimental proton-proton distances were obtained as described in the experimental section and compared to those estimated by the MM3* molecular mechanics and dynamics calculations (Table 1).

The ensemble averaged distances computed on the basis of the population ratios obtained from MM3* agrees reasonably well with those experimentally deduced from the NOE values (see experimental section). Both sets of data support the presence of a conformational equilibrium among several conformers. However, some experimental distances are slightly different from those calculated from the MM3 distribution. Thus, the relative weakness of the 1Man-2Gal NOE and the very small intensity of 2Man-2Gal, which is exclusive for conformer D, indicates that a major contribution from conformer D is unlikely. However the fact that this NOE is at all observed suggests that the 0.3% deduced from MM3* is underestimated. The presence of conformers A and B is also granted since the 1Gal-2Man and 1Gal-1Man NOEs are exclusive for these geometries. In this case the MM3* prediction appears to be somewhat high. The presence of the global minimum C is only grounded on the MM3* calculations and cannot be directly demonstrated by NMR because its exclusive NOE cannot be determined, due to overlapping between the two key protons (H1 Gal and H5 Man show the same chemical shift). Thus, although the experimental data was qualitatively consistent with the calculated trends, it was not definitive, as the experimental NOE values could also fit other population distributions. To examine this possibility, a systematic variation of the populations of the four conformers was then performed and the computed distances were compared to the experimental ones.31 Using this protocol, it was deduced that the relative percentages of the observable NOEs can only be accounted for when a significant population of C is considered. Attempts to fit all the observable NOEs (see Table 1) when minimum C was not considered did not succeed. In fact, the best ft to the experimental NOEs is obtained when a 25:15:50:10 distribution of A:B:C:D is considered. Therefore, compound 5 exists predominantly as a conformational equilibrium between natural and non-natural conformers20 with substantial (∼0%) non exo-anomeric conformations around the ΦGal glycosidic linkage, and detectable, ∼35%, contribution of the nonexo-anomeric conformer for ΦMan. Thus, overall, the MM3* simulations within MACROMODEL32 agree reasonably well with the observed populations.

3. Conclusion

As described in earlier studies, the conformational distributions around the glycosidic linkages of the parent O-glycoside 1 and its C-glycoside analogue, 2, are rather different. The O-glycoside populates almost entirely (>93%) the natural exo-Gal/exo-Man (B) conformation, whereas the C-glycoside exists in this conformation in only 30%, with four other conformational families A (42%), C (6%), D (10%) and E (12%.12 The monofluorinated analogue 3 shows a high preference for A (90%). The present investigation indicates that the difluoro-C-glycoside 5 populates the non-exo-Gal/exo-Man conformer C to a major extent (ca 50%), with additional contributions (∼10–25%) from A, B, and D. Thus 5 might not be an accurate mimetic of the O-glycoside 1, if the active conformation corresponds to the ground state of 1. Difluoro-C-glycosides mimics like 5 could be more effective in cases where the glycosidic oxygen of the parent O-glycoside interacts directly with the receptor. This relative activity of 5 with different carbohydrate receptors is an avenue for future investigation.

4. Experimental

4.1 Synthetic General Methods

Unless otherwise stated, all reactions were carried out under a nitrogen atmosphere in oven-dried glassware using standard syringe and septa technique. 1H and 13C NMR spectra were obtained on a Varian Unity Plus 500 (500 MHz) spectrometer. Chemical shifts are relative to the deuterated solvent peak or the tetramethylsilane (TMS) peak at (δ 0.00) and are in parts per million (ppm). Assignments for selected nuclei were determined from 1H COSY experiments. High-resolution mass spectrometry (HRMS) was performed on an Ultima Micromass Q-Tof instrument at the Mass Spectrometry Laboratory of the University of Illinois, Urbana-Champaign. Thin layer chromatography (TLC) was done on 0.25 mm thick precoated silica gel HF254 aluminum sheets. Chromatograms were observed under UV (short and long wavelength) light, and were visualized by heating plates that were dipped in a solution of ammonium (VI) molybdate tetrahydrate (12.5 g) and cerium (IV) sulfate tetrahydrate (5.0 g) in 10% aqueous sulphuric acid (500 mL). Flash column chromatography (FCC) was performed using silica gel 60 (230–400 mesh) and employed a stepwise solvent polarity gradient, correlated with TLC mobility.

4.2 (3S) Ethyl 3-acetoxy-4,5,6-tris(benzyloxy)-2,2-difluorooct-7-enoate [(S)-12] and (3R) Ethyl 3-acetoxy-4,5,6-tris(benzyloxy)-2,2-difluorooct-7-enoate [(R)-12]

To a solution of activated zinc dust (13.2 g, 0.21 mol) in dry THF at reflux (30 mL) was added ethyl bromodifluoroacetate (19.1 mL, 0.15 mol). After 10 min, a solution of 1120 (20.0 g, 0.05 mmol) in THF (60 mL) was introduced dropwise over 30 min. The mixture was then heated at reflux for 3 h, cooled to rt and carefully poured into 1N HCl (40 mL) and ice (40 g), and extracted with EtOAc (3 × 150 mL). The organic layer was washed with saturated aqueous NaHCO3, and brine, dried (Na2SO4), and concentrated in vacuo. FCC of the residue gave a mixture of epimeric alcohols (13.9 g, 54%) in a 3:1 ratio; colorless oil; Rf = 0.29 (10% EtOAc/petroleum ether); 1H NMR (CDCl3) δ 1.74 (t, J = 7.1 Hz, 2.3H), 1.32 (t, J = 7.1 Hz, 0.7H), 3.38 (dd, J = 3.2, 10.0 Hz, 0.3H), 3.58 (m, 0.7H) 3.77 (m, 0.3H), 3.86 (m, 1.7H), 3.94–4.08 (m, 1.7H), 4.11–4.22 (m, 0.7H), 4.31 (q, J = 7.1 Hz 0.6H), 4.40–4.87 (m, 7H), 5.37-5.50 (m, 2H), 5.92 (m, 0.7H), 6.03 (m, 0.3H), 7.27–7.39 (m, 15H); 13C NMR (CDCl3) major isomer: δ 13.8, 62.5, 70.4, 75.2, 78.9 (d, J = 3.9 Hz), 81.6, 82.9, 114.8 (dd, J = 257.3, 257.4 Hz), 120.0, 127.9, 128.1-128.6 (several resonances), 135.3, 137.4, 138.01, 138.4, 163.4 (t, J = 30.8 Hz). Minor isomer: δ 14.0, 63.2, 70.4, 70.6, 73.9 (d, J = 3.4 Hz), 74.3, 75.3, 80.0, 81.7, 119.5, 127.0-129.0 (several resonances) 135.8, 137.6, 137.99, 138.2, 163.6 (dd, J = 30.0, 33.1 Hz). ESIMS calcd for C31H38O6F2N [M + NH4]+: 558.2662. Found: 558.2651.

A portion of the above mixture (0.52 g, 1.09 mmol) was dissolved in EtOAc (30 mL) and treated with acetic anhydride (0.52 mL, 5.45 mmol) and DMAP (26.6 mg, 0.22 mmol) for 30 min. MeOH (1 mL) was added and the volatiles removed under reduced pressure, FCC of the residue afforded (S)-12 (0.40 g, 64%) and (R)-12 (0.13 g, 21%) as colorless oils.

For (S)-12: Rf = 0.38 (10% EtOAc/petroleum ether); [α]D -21.0 (c 1.5, CHCl3); IR (film) 1767 (s) cm−1; 1H NMR (CDCl3) δ 1.08 (t, J = 7.1 Hz, 3H), 2.20, (s, 3H), 3.74 (d, J = 8.1 Hz, 1H), 3.92 (q, J = 7.1 Hz, 1H), 4.06 (m, 3H), 4.41 (A of ABq, J = 10.8 Hz, Δδ = 0.15 ppm, 1H), 4.44 (A of ABq, J = 12.2 Hz, Δδ = 0.25 ppm, 1H), 4.56 (B of ABq, J = 10.8 Hz, Δδ = 0.15 ppm, 1H), 4.68 (B of ABq, J = 12.2 Hz, Δδ = 0.25 ppm, 1H), 4.87 (ABq, J = 12.0 Hz, Δδ = 0.04 ppm, 2H), 5.39 (d, J = 17.1 Hz, 1H), 5.46 (dd, J = 1.2, 10.5 Hz, 1H), 5.81 (ddd, J = 7.8, 10.5, 17.4 Hz, 1H), 6.00 (ddd, J = 3.2, 10.5, 20.8 Hz, 1H), 7.19–7.44 (m, 15H); 13C NMR (CDCl3) δ 13.7, 20.6, 62.8, 69.4 (t, J = 22.0 Hz), 70.5, 73.0, 75.0, 77.3 (d, J = 2.7 Hz), 81.2, 81.8, 113.3 (dd, J = 251.1, 257.5 Hz), 120.4, 127.9-128.7 (several resonances), 135.0, 137.1, 138.4, 138.8, 162.3 (dd, J = 28.9, 33.1 Hz), 168.4. ESIMS calcd. for C33H40O7F2N [M + NH4]+; 600.2767. Found: 600.2761.

For (R)-12: Rf = 0. 28 (10% EtOAc/petroleum ether); 1H NMR (CDCl3) δ 1.23 (t, J = 7.1 Hz, 3H), 2.07 (s, 3H), 3.78 (dd, J = 4.2, 6.5 Hz, 1H), 4.20 (m, 4H), 4.38–4.25 (m, 2H), 4.64–4.80 (m, 4H), 5.42 (d, J = 10.4 Hz, 1H), 5.48 (d, J = 17.3Hz, 1H), 5.80 (ddd, J = 2.2, 12.7, 19.9 Hz, 1H), 6.01 (ddd, J = 7.8, 10.4, 17.6 Hz, 1H), 7.28–7.43 (m, 15H); 13C NMR (CDCl3) δ 13.9, 20.7, 63.3, 70.0 (dd, J = 24.6, 28.6 Hz) 73.2, 74.2, 75.1, 80.6, 81.8, 113.2 (dd, J = 255.2, 257.4 Hz), 119.4, 127.7–128.5 (several resonances), 135.9, 138.1, 138.4, 138.5, 162.8 (dd, J = 30.3, 32.9 Hz), 168.5. ESIMS calcd for C33H40O7F2N [M + NH4]+: 600.2767. Found: 600.2753.

4.3 (3S)- Methyl 4,5,6-tris(benzyloxy)-2,2-difluorooct-7-enoate (S)-13

A solution of ethyl ester-acetate (S)-12 (1.11 g, 1.90 mmol) in dry MeOH (20 mL) was treated with 1M MeONa in MeOH (5.7 mL, 5.7 mmol). After stirring for 1 h at rt, the reaction was neutralized with 2N HCl and the solvent evaporated under reduced pressure. FCC of the residue afforded (S)-13 (0.79 g, 83%) as a colorless oil; Rf = 0.54, (10% EtOAc/petroleum ether); 1H NMR (CDCl3) δ 3.50 (s, 3H), 3.52 (m, 1H), 3.84 (m, 2H), 4.11 (t, J = 7.1 Hz, 1H), 4.36-4.73 (m, 5H), 4.83 (s, 2H), 5.37 (d, J = 18.6 Hz, 1H), 5.41 (d, J = 18.6 Hz, 1H), 5.90 (ddd, J = 8.3, 10.0, 17.6 Hz, 1H), 7.14–7.46 (m, 15H); 13C NMR (CDCl3) δ 52.9, 70.7 (t, J = 22.9 Hz), 70.8, 72.9, 75.3, 77.3 (d, J = 2.7 Hz), 81.2, 81.8, 113.3 (dd, J = 251.1, 257.5 Hz), 120.4, 127.9– 128.7 (several resonances), 135.0, 137.1, 138.4, 138.8, 163.8 (dd, J = 30.2, 32.1 Hz). ESIMS calcd for C30H36O6F2N [M + NH4]+: 544.2505. Found: 544.2505.

4.3 Epoxide mixture 14

To a solution of (S)-13 (0.79 g, 1.50 mmol) in CH2Cl2 (20 mL) was added a mixture of m-CPBA (2.61 g, 15.1 mmol), CH2Cl2 (20 mL), NaH2PO4 (4.30 g, 30.3 mmol), Na2HPO4 (4.14 g, 30.0 mmol) and water (40 mL). The suspension was stirred for 26 h at rt then poured into 10% Na2SO3 in saturated aqueous NaHCO3. After stirring for 1 h, the organic layer was separated, washed with brine, dried (Na2SO4) and evaporated under reduced pressure. FCC of the residue afforded 14 (0.50 g, 74% based on recovered alkene) as a 2:1 mixture; clear oil; Rf = 0.30 (15% EtOAc/petroleum ether); 1H NMR (CDCl3) δ 2.47 (dd, J = 2.7, 4.9 Hz, 0.6H), 2.60 (t, J = 4.5 Hz, 0.6H), 2.68 (dd, J = 2.6, 4.9 Hz, 0.4H), 2.84 (t, J = 4.6 Hz, 0.4H), 3.09 (m, 0.4H), 3.36 (m, 0.6H), 3.30 (m, 0.6H), 3.53–3.60 (m, 3.8H), 3.68 (m, 0.6H), 3.91 (m, 1.6H), 4.01 (d, J = 5.9 Hz, 0.4H), 4.45–4.90 (m, 7H), 7.18–7.40 (m, 15H); 13C NMR (CDCl3) major isomer: δ 43.9, 52.7, 53.1, 70.6 (t, J = 22.5 Hz), 73.9, 74.4, 78.9 (d, J = 3.3 Hz), 80.8, 80.9, 114.9 (dd, J =250.0, 258.1 Hz), 122.9–128.7 (several resonances), 137.4, 137.9, 1381, 138.4, 138.8, 163.8 (dd, J = 30.2, 32.3 Hz). Minor isomer: δ 47.2, 51.1, 53.0, 70.1 (t, J = 25.1 Hz), 73.4, 75.2, 78.8 (d, J = 3.4 Hz), 79.5, 81.5, 115.0, (dd, J = 250.0, 256.9 Hz), 137.2, 137.7, 138.3, 163.7 (31.3 Hz). ESIMS calcd for C30H36O7F2N [M + NH4]+: 560.2454. Found: 560.2452.

4.4 Methyl 3,7-anhydro-4,5,6-tri-O-benzyl-2,2-difluoro-d-glycero-d-talo-octosonate and methyl 3,7-anhydro-4,5,6-tri-O-benzyl-2,2-difluoro-l-glycero-d-talo-octosonate (15)

A solution of 14 (4.19 g, 7.73 mmol) in dry MeOH (400 mL) was treated with 1M MeONa in MeOH (23.2 mL, 23.2 mmol). After stirring for 23 h at rt, the reaction was acidified to pH 2 with a soution of HCl in ether and the solvent evaporated under reduced pressure. The residue was dissolved in MeOH (20 mL) and toluene (60 mL) then treated with TMSCHN2 (5.8 mL, 11.6 mmol, 2M solution in ether) at 0 °C. After 30 min, acetic acid (1 mL) was added to the reaction and the volatiles removed under reduced pressure. FCC of the residue yielded 15 (2.16 g, 52%) as an inseparable mixture, and 16 (0.95 g, 22%).

For 15: colorless oil, Rf = 0.49 (30% EtOAc/petroleum ether); 1H NMR (CDCl3) δ 1.66 (d, J = 8.9 Hz, D2O exchange, 0.5H), 1.87 (t, J = 6.2 Hz, D2O exchange, 0.5H), 3.42 (dd, J = 1.2, 3.3 Hz, 0.5H), 3.50 (m, 0.5H), 3.65 (m, 2H), 3.75–3.98 (m, 5.5H), 4.08 (dd, J = 3.2, 5.2 Hz, 0.5H), 4.28–4.72 (m, 7H), 7.15–7.38 (m, 15H); 13C NMR (CDCl3) δ 53.0, 53.4, 61.7, 62.0, 71.4, 71.9, 72.0, 72.4, 72.5, 72.7–73.2 (several resonances), 73.4, 74.3, 74.8, 75.7, 76.9, 114.0 (t, J = 254.7 Hz), 114.9 (dd, J = 256.3, 260.3 Hz), 127.7–128.6 (several resonances), 137.4, 137.6, 137.9, 138.0, 163.37 (t, J = 30.9 Hz), 163.40 (dd, J = 27.0, 31.8 Hz). ESIMS calcd for C30H36O7F2N [M + NH4]+: 560.2454. Found: 560.2489.

For 16: colorless oil, Rf = 0.60 (30% EtOAc/petroleum ether); 1H NMR (CDCl3) δ 3.13 (d, J = 8.3 Hz, D2O exchange, 1H), 3.62 (s, 3H), 3.71 (m, 1H), 3.77 (dd, J = 4.9, 12.6 Hz, 1H), 3.83 (t, J = 5.2, 1H), 4.02 (d, J = 6.0 Hz, 1H), 4.06 (d, J = 12.7 Hz, 1H), 4.33–4.44 (m, 4H), 4.60 (s, 2H), 4.70 (ABq, J = 11.8 Hz, Δδ = 0.03 ppm, 2H), 7.25–7.37 (m, 15H); 13C NMR (CDCl3) δ 53.3, 66.5, 67.2, 72.0, 72.5, 73.3, 74.1, 75.2, 80.1, 115.7 (t, J = 255.7 Hz), 127.1–128.8 (several resonances), 137.5, 137.7, 138.0, 163.8 (t, J = 31.5 Hz). ESIMS calcd for C30H36O7F2N [M + NH4]+: 560.2454. Found: 560.2451.

4.5 Methyl 3,7-anhydro-4,5,6-tri-O-benzyl-8-O-t-butyldiphenylsilyl-2,2-difluoro-d-glycero-d-talo-octosonate (17) and methyl 3,7-anhydro-4,5,6-tri-O-benzyl-8-O-t-butyldiphenylsilyl-2,2-difluoro-l-glycero-d-talo-octosonate (19)

The mixture 15 (213 mg, 0.39 mmol), TBDPSCl (0.03 mL, 1.18 mmol), and imidazole (106 mg, 1.56 mmol) in anhydrous DMF (5 mL) was stirred at 50 °C for 2.5 h. The reaction was then quenched by the addition of MeOH (1 mL) and extracted with ether. The combined organic phase was washed with brine, dried (Na2SO4), filtered, and evaporated under reduced pressure. The residue was purified by gravity column chromatography to give 17 (180 mg, 59%) and 19 (119 mg, 39%).

For 17: colorless oil, Rf = 0.68 (10% EtOAc/petroleum ether); IR (film) 1770 (s) cm−1; 1H NMR (CDCl3) δ 1.11 (s, 9H), 3.69 (s, 3H), 3.91 (dd, J = 6.4, 12.5 Hz, 1H), 3.94–4.00 (m, 3H), 4.07 (t, J = 5.9 Hz, 1H), 4.13 (dd, J = 3.2, 5.6 Hz, 1H), 4.51 (dd, J = 5.6, 10.5, 19.0 Hz, 1H), 4.60–4.71 (m, 6H), 7.26 (m, 2H), 7.34–7.50 (m, 19H), 7.72 (m, 4H); 13C NMR (CDCl3) δ 26.9, 53.4, 62.8. 72.3, 72.87, 72.94 (dd, J = 22.3, 27.0 Hz), 73.5, 74.1, 77.4, 115.2 (dd, J = 256.5, 258.8 Hz), 127.8–129.8 (several resonances), 133.5, 133.8, 135.8, 136.0, 137.9, 138.3, 138.4, 163.6 (t, J = 31.4 Hz). ESIMS calcd for C46H54O7SiF2N [M + NH4]+: 798.3632 found 798.3637.

For 19: colorless oil, Rf = 0.62 (10% EtOAc/petroleum ether); 1H NMR (CDCl3) δ 1.09 (s, 9H), 3.61 (s, 3H), 3.67 (dd, J = 1.1, 3.7 Hz, 1H), 3.75 (t, J = 2.7 Hz, 1H), 3.81 (m, 2H), 3.96 (dd, J = 2.6, 10.0 Hz, 1H), 4.03 (t, J = 6.8 Hz, 1H), 4.32–4.70 (m, 5H), 4.48 (A of ABq, J = 12.1 Hz, Δδ = 0.21 ppm, 1H), 4.69 (B of ABq, J = 12.1 Hz, Δδ = 0.21 ppm, 1H), 7.16 (m, 2H), 7.28-7.47 (m, 19H), 7.67 (m, 4H); 13C NMR (CDCl3) δ 27.0, 53.2, 62.3. 72.0, 72.1, 73.1, 73.2, 73.4 (two resonances, a singlet and an apparent t, J = 23.0 Hz), 74.8, 75.7, 114.3 (t, J = 254.5 Hz), 127.9–128.8 (several resonances), 133.4, 133.7, 135.7, 135.8, 137.8, 138.4 (two resonances), 163.7 (t, J = 31.3 Hz). ESIMS calcd for C46H54O7SiF2N [M + NH4]+: 798.3632 found 798.3630.

4.6 3,7-Anhydro-4,5,6-tri-O-benzyl-8-O-t-butyldiphenylsilyl-2,2-difluoro-d-glycero-d-talo-octosonic acid (18)

Methyl ester 17 (1.70 g, 2.18 mmol) was treated with a mixture of 3N NaOH (2.2 mL, 6.54 mmol) and ethanol (40 mL). After 1 hour the reaction mixture concentrated in vacuo and acidified with 2N HCl (20 mL). The mixture was then extracted with EtOAc and the organic phase washed with water, dried (Na2SO4) and evaporated under reduced pressure to provide 18 (1.60 g, 94%); colorless oil, Rf = 0.34 (20% MeOH/CHCl3); 1H NMR (CDCl3) δ 1.05 (s, 9H, (CH3)3CSi), 3.87–4.05 (m, 5H, H-4, 6, 7, 8a, 8b), 4.14 (dd, J = 2.9, 6.2 Hz, 1H, H-5), 4.48–4.66 (m, 7H, H-3, 3 × PhCH2), 7.24–7.48 (m, 21H, Ph), 7.71 (m, 4H, Ph); 13C NMR (CDCl3) δ 27.0, 27.2 (CH3)3CSi), 62.6 (C-8), 72.1 (t, J = 24.1 Hz) (C-4), 72.37, 72.43, 72.9, 73.1, 73.8, 76.2, 77.5 (7C, C-4, 5, 6, 3 × PhCH2), 114.6 (t, J = 257.0 Hz) (C-2), 127.7–129.9 (several resonances), 133.4, 133.6, 135.8, 135.9, 137.6, 138.0, 138.2 (Ph), 166.4 (t, J = 31.7 Hz) (C-1). ESIMS calcd for C45H52O7SiF2N [M + NH4]+: 784.3476 found 784.3464.

4.7 Methyl 4,5,6-tri-O-acetyl-3,7-anhydro-8-O-t-butyldiphenylsilyl-2,2-difluoro-d-glycero-d-talo-octosonate (20)

Colorless oil; Rf = 0.44 (30% EtOAc/petroleum ether); 1H NMR (CDCl3) δ 1.08 (s, 9H, (CH3)3−), 1.99, 2.00, 2.12 (all s, 9H, CH3CO × 3), 3.71 (dd, J = 3.2, 11.7 Hz, 1H, H-6a), 3.75 (dd, J = 4.7, 11.7 Hz, 1H, H-6b), 3.82 (s, 3H, CH3O−), 3.98 (m, 1H, H-5), 4.42 (ddd, J = 3.6, 6.6, 23.4 Hz, 1H, H-1), 5.38 (dd, J = 3.6, 8.3 Hz, 1H, H-3), 5.43 (t, J = 8.3 Hz, 1H, H-4), 5.65 (t, J = 3.4 Hz, 1H, H-2), 7.36–7.42 (m, 6H), 7.64–7.71 (m, 4H); 13C NMR (CDCl3) δ 20.8 (two resonances), 20.9, 26.9, 53.9, 62.5, 65.7, 66.1, 69.4 (d, J = 4.3 Hz), 74.3 (dd, J = 22.0, 30.0 Hz), 76.4, 114.5 (dd, J = 258.1, 262.1 Hz), 127.9 (two resonances), 128.5, 130.0, 133.2, 133.4, 135.8, 135.9, 162.9 (dd, J = 29.2, 32.7 Hz), 169.5, 169.7, 169.9. ESIMS calcd for C31H42O10SiF2N [M + NH4]+: 654.2541. Found: 654. 2537.

4.8 Methyl 4,5,6,8-tetra-O-acetyl-3,7-anhydro-2,2-difluoro-l-glycero-d-talo-octosonate (21)

Colorless oil; Rf = 0.42 (40% EtOAc/petroleum ether); 1H NMR (C6D6) δ 1.98, 2.06, 2.20 (all s, 12H, CH3CO × 4), 3.91 (s. 3H, CH3O−), 4.14–4.16 (m, 2H, H-5, 6a), 4.17 (t, J = 5.9 Hz, 1H, H-6b), 4.34 (ddd, J = 7.8, 8.3, 14.4 Hz, 1H, H-1), 5.00 (dd, J = 1.5, 3.9 Hz, 1H, H-4), 5.40 (dd, J = 3.2, 10.3 Hz, 1H, H-2), 5.43 (t, J = 3.2 Hz, 1H, H-3); 13C NMR (CDCl3) δ 20.6, 20.8 20.9 (two resonances), 53.6, 61.9, 63.9 (d, J = 4.2 Hz), 66.6, 67.8, 72.9 (dd, J = 23.8, 28.4 Hz), 73.0, 113.6 (dd, J = 252.0, 261.5 Hz), 163.2 (dd, J = 30.2, 32.2 Hz), 169.0 (two resonances), 169.7, 170.5. ESIMS calcd for C17H26O11F2N [M + NH4]+: 458.1468. Found: 458,1467.

4.9 Ester (22)

A mixture of acid 18 (43 mg, 0.06 mmol), 2,4,6-trichlorobenzoyl chloride (0.01 mL, 0.06 mmol) and triethylamine (0.02 mL, 0.12 mmol) in THF (3 mL) was stirred for 3.5 h at 0 °C. DMAP (10.0 mg, 0.08 mmol) and a solution of alcohol 6 (31 mg, 0.06 mmol) in toluene were added, and stirring continued for 1 h. The mixture was then diluted with ether (10 mL), washed with saturated aqueous NaHCO3 and brine, dried (Na2SO4), filtered, and evaporated under reduced pressure. The residue was purified by FCC to give ester 22 (54 mg, 91% based on recovered 6, 76% based on consumed 18); colorless oil; Rf = 0.33 (10% EtOAc/petroleum ether); [α]D -32.2 (c 1.0, CHCl3); IR (film) 1780 (s) cm−1; 1H NMR (CDCl3) δ 1.04 (two singlets, 18H, 2 × (CH3)3CSi), 1.31, 1.43, (both s, 6H, C(CH3)2), 3.77–3.89 (m, 5H, H-4'a, 4'b, 5, 8a, 8b), 3.91 (q, J = 5.1 Hz, 1H, H-7), 3.99 (t, J = 5.9 Hz, 1H, H-6), 4.07 (dd, J = 3.0, 5.6 Hz, 1H, H-4), 4.39–4.60 (m, 8H, H-2', 3, 3 × PhCH2), 5.22 (m, 1H, H-3'), 5.42 (d, J = 6.6 Hz, 1H, H-1'), 7.16–7.42 (m, 30H, Ph), 7.52 (m, 2H, Ph ), 7.65 (m, 8H, Ph); 13C NMR (CDCl3) δ 26.7, 26.9, 27.0, 27.2, 61.6, 62.8, 72.5, 72.6, 72.7, 72.9, 73.2, 74.0, 74.5, 77.1, 77.6, 78.7, 84.7, 112.1, 114.9 (t, J = 257.4 Hz), 127.8–129.8 (several resonances), 130.0, 132.6, 132.9, 133.0, 133.4, 133.5, 133.8, 135.8 (three resonances), 135.9, 136.0, 137.8, 138.4, 138.5, 162.4 (t, J = 31.8 Hz). ESIMS calcd for C74H86O10SSi2F2N [M + NH4]+: 1274.5474. Found: 1274.5476.

4.10 Enol ether (23)

TMEDA (1.20 mL, 7.96 mmol) was added at 0 °C to a mixture of 1M titanium tetrachloride in CH2Cl2 (4.98 mL, 4.98 mmol) and THF (6 mL). The resulting yellow-brown suspension was allowed to warm to rt and stirred for 30 min. At this point freshly activated zinc dust (546 mg, 8.36 mmol) and lead (II) chloride (28 mg, 0.10 mmol) were added in one portion and stirring continued for 10 min. To the resulting bluish-green mixture was added a solution of ester 22 (257 mg, 0.20 mmol) and dibromomethane (0.28 mL, 3.98 mmol) in THF (6 mL). The mixture was stirred at 60 °C for 3.5 h then diluted with brine, and cooled to rt over 30 min. Ether (20 mL) was then added and vigorous stirring continued for 20 min. The suspension was filtered through neutral alumina and the residue washed with ether. The ethereal extract was concentrated in vacuo and gravity chromatography of the residue over silica gel afforded enol ether 23 (101 mg, 63%, based on recovered 22); colorless oil; Rf = 0.53 (5% EtOAc/petroleum ether); 1H NMR (C6D6) δ 1.15, 1,17 (both s, 18H, 2 × (CH3)3CSi), 1.47, 1.55, (both s, 6H, C(CH3)2), 3.81 (dd, J = 5.9, 11.0 Hz, 1H, H-8a), 4.01–4.15 (m, 5H, H-3', 4'a, 6, 7, 8b), 4.18 (dd, J = 7.3, 11.0 Hz, 1H, H-4'b), 4.31 (apparent t, J = 2.5 Hz, 1H, H-6), 4.35 (t, J = 3.7 Hz, 1H, H-9a), 4.43–4.49 (m, 4H, H-4, 3 × PhCH), 4.62 (A of ABq, J = 11.9 Hz, Δδ = 0.14 ppm, 1H, PhCH), 4.69 (B of ABq, J = 11.9 Hz, Δδ = 0.14 ppm, 1H, PhCH), 4.75 (d, J = 3.7 Hz, 1H, H-9b), 4.79 (dd, J = 2.7, 5.6 Hz, 1H, H-2'), 4.87 (d, J = 11.3 Hz, 1H, PhCH), 5.08 (ddd, J = 1.7, 7.6, 26.7 Hz, 1H, H-1), 6.22 (d, J = 5.6 Hz, 1H, H-1'), 6.89–7.43 (m, 30H, Ph), 7.65–7.88 (m, 10H, Ph); 13C NMR (C6D6) δ 27.3, 27.4, 27.6, 27.9, 62.1, 65.2, 72.6, 73.0, 73.5, 74.7 (dd, J = 22.0, 32.1 Hz), 75.0, 75.2, 78.9 (d, J = 4.6 Hz), 81.0, 84.9, 88.3 (t, J = 4.6 Hz), 113.1, 119.8 (dd, J = 248.4, 253.9 Hz), 127.3–129.5 (several resonances), 130.2 (two resonances), 130.6 (two resonances), 131.6, 133.6, 133.8, 134.5, 134.6, 135.5, 136.4, 136.5, 139.1, 139.5, 139.7, 154.3 (dd, J = 23.8, 31.2 Hz). ESIMS calcd for C75H88O9SSi2F2N [M + NH4]+: 1272.5681. Found: 1272.5671.

4.11 Glycal (24)

Enol ether 23 (200 mg, 0.16 mmol), 2,6-di-tert-butyl-4-methylpyridine (163 mg, 1.59 mmol), and freshly activated, powdered 4A molecular sieves (400 mg) in anhydrous CH2Cl2 (15 mL) were stirred for 15 min at rt under an argon atmosphere and then cooled to 0 °C. Methyl triflate (0.18 mL, 0.80 mmol) was then introduced, and the mixture was warmed to rt and stirred for an additional 2 d, at which time triethylamine (0.2 mL) was added. The mixture was diluted with ether, washed with saturated aqueous NaHCO3 and brine, dried (Na2SO4), filtered and evaporated under reduced pressure. The residue was purified by FCC to give glycal 24 (124 mg, 82% based on recovered 23), clear oil, Rf = 0.54 (10% EtOAc/petroleum ether); 1H NMR (C6D6) δ 1.16, 1,18 (both s, 18H), 1.27, 1.28, (both s, 6H), 3.86 (t, J = 6.9 Hz, 1H), 4.03–4.17 (m, 7H), 4.30 (t, J = 2.9 Hz, 1H), 4.38 (m, 1H), 4.50–4.60 (m, 5H), 4.72 (A of ABq, J = 11.5 Hz, Δδ = 0.23 ppm, 1H), 4.79 (apparent ddd, J = 2.9, 10.0, 22.7 Hz, 1H), 4.98 (B of ABq, J = 11.5 Hz, Δδ = 0.23 ppm, 1H), 5.41 (d, J = 2.7 Hz, 1H), 7.08-7.38 (m, 27H), 7.70–7.87 (m, 8H); 13C NMR (C6D6) δ 27.4, 27.5, 28.8, 63.7, 63.8, 69.3, 72.2, 73.0, 73.3, 74.0, 74.9, 75.2 (dd, J = 24.7, 30.2 Hz), 77.5, 78.5, 80.3 (d, J = 2.7 Hz), 102.7 (t, J = 5.5 Hz), 111.3, 118.8 (dd, J = 247.4, 252.0 Hz), 127.9–128.9 (several resonances), 133.9, 134.1 (two resonances), 136.2, 136.3, 136.4, 136.7, 139.2, 139.5, 139.9, 148.5 (dd, J = 26.6, 31.2 Hz). ESIMS calcd for C69H82O9Si2F2N [M + NH4]+: 1162.5491. Found: 1162.5497.

4.12 2,6:8,12-dianhydro-9,10,11-tri-O-benzyl-1,13-di-O-tert-butyldiphenylsilyl-3,4-O-isopropylidene-7-deoxy-7,7-difluoro-d-erythro-l-allo-l-galacto-tridecitol (25)

Borane dimethyl sulfide complex (0.11 mL, 1.10 mmol) was added at 0 °C to a solution of glycal 24 (0.12 g, 0.11 mmol) in anhydrous THF (10 mL) under an atmosphere of argon. The mixture was warmed to rt and stirred for an additional 2 h at this temperature. The solution was then cooled to 0 °C and treated with a mixture of 3N NaOH (6 mL) and 30% aqueous H2O2 (6 mL) for 30 min. The mixture was diluted with ether, washed with saturated aqueous NaHCO3 and brine, dried (Na2SO4), filtered and evaporated under reduced pressure. The residue was purified by FCC to give 25 (0.11 g, 86%) as a colorless oil; Rf = 0.48 (20% EtOAc/petroleum ether); IR (film) 3441 (m) cm−1; 1H NMR (CDCl3) δ 1.07 (s, 18H, 2 × CH3)3CSi), 1.35, 1.47, (both s, 6H, C(CH3)2), 2.93 (d, J = 5.3 Hz, 1H, D2O exchange, -OH), 3.54 (m, 1H, H-1'), 3.68 (t, J = 7.6 Hz, 1H, H-4), 3.79 (ddd, J = 2.2, 6.1, 7.8 Hz, 1H, H-5'), 3.80-3.97 (m, 8H, H-2', 3', 6'a, 6'b, 3, 5, 6a, 6b), 4.09 (t, J = 3.4, Hz, 1H, H-2), 4.27 (dd, J = 2.5, 5.1 Hz, 1H, H-4'), 4.36 (d, J = 11.3 Hz, 1H, PhCH), 4.50–4.62 (m, 6H, H-1, 5 × PhCH), 7.06 (m, 2H, Ph), 7.22–7.42 (m, 25H, Ph), 7.65–7.73 (m, 8H, Ph); 13C NMR (CDCl3) δ 26.5, 27.0, 27.3, 28.5, 62.7, 64.3, 69.7, 72.8 (two resonances), 72.9, 73.4, 74.0, 74.5, 76.6 (apparent t, J = 31.9 Hz), 78.2, 78.7, 80.2, 109.9, 121.2 (t, J = 254.2 Hz), 127.8–130.0 (several resonances), 133.2, 133.5, 133.7, 135.8, 135.9, 136.0, 138.2, 138.3, 138.5. ESIMS calcd for C69H84O10Si2F2N [M + NH4]+: 1180.5596. Found: 1180.5601.

4.13 2,6:8,12-dianhydro-7-deoxy-7,7-difluoro-d-erythro-l-allo-l-galacto-tridecitol (5)

A saturated solution of HCl in ether (0.2 mL) was added to a solution of C-glycoside 25 (87 mg, 0.07 mmol) in anhydrous MeOH (8.0 mL) to a pH of 4. The mixture was stirred at rt and after 2.5 h, the volatiles were removed under reduced pressure. FCC of the crude residue provided the pentol derivative resulting from removal of the acetal and silyl ether protecting groups (30 mg, 63% yield): Rf = 0.28 (95% EtOAc/petroleum ether); 1H NMR (CDCl3) δ 2.24 (broad s, D2O exchange, 2H), 3.41 (s, 2H), 3.53 (m, 2H), 3.70 (m, 3H). 3.79 (m, 1H), 3.85 (t, J = 9.5 Hz, 1H), 3.96 (apparent t, J = 5.0 Hz, 1H), 4.02 (s, 1H), 4.11 (m, 2H), 4.38–4.61 (m, 7H), 4.84 (broad s, 1H), 7.17–7.33 (m, 15H). ESIMS calcd for C34H40O10F2Na [M + Na]+: 669.2482. Found: 669.2480.

A mixture of material from the previous step (12 mg, 0.02 mmol), 10% Pd–C (30 mg), formic acid (0.05 mL) and CH3OH (3 mL) was stirred under an atmosphere of hydrogen (balloon), for 18 h. The reaction mixture was then purged with argon, filtered through a bed of Celite and the filtrate concentrated under reduced pressure to give 5 (8 mg, 93%) as a colorless oil; Rf = 0.32 (50% MeOH/CH3Cl); [α]D +25.1 (c 0.75, H2O); 1H NMR (see Table 2); 13C NMR (D2O) δ 61.2, 61.4, 66.3, 66.7, 66.9, 68.8, 71.1 (d, J = 2.6 Hz), 73.9, 76.3 (dd, J = 22.9, 26.6 Hz), 76.9 (t, J = 22.9 Hz), 77.9, 79.3, 121.6 (dd, J = 251.1, 253.9 Hz); ESIHRMS calcd for C13H22O10F2Na [M + Na]+: 399.1073. Found: 399.1070.

4.14 Molecular modeling

Potential energy surfaces and population maps were calculated using the MM3* force field,23 as implemented in MACROMODEL 7.1.32 torsion angle ΦMan is defined as H1Man–C1Man–CF2–C1Gal and ΦGal as H1Gal–C1Gal–CF2 –C1Man. In a first step, a rigid ΦMan/ΦGal map was calculated by using a grid step of 18° at each torsion coordinate.33,34 The corresponding 400 conformers were optimized by fixing ΦMan/ΦGal at each corresponding value to generate the relaxed energy map. The probability distribution was calculated from the energy values according to a Boltzmann function at 300 K. In all the molecular mechanics and dynamics calculations, the GB/SA solvation model for water was used.

The molecular dynamics simulations were also performed using the MM3* force field within MACROMODEL 7.1. For molecular dynamics simulations, several geometries, corresponding to the different low energy minima were used as input. A temperature simulation of 300 K was employed with a time step of 1.5 fs and an equilibration time of 100 ps. The total simulation times for each compound was 3 ns.

4.15 NMR spectroscopy

1H-NMR (500 MHz) spectra were recorded at 30 °C in D2O, on a Bruker AVANCE 500 spectrometer. Concentrations of ca. 5 mM of 5 were used. Chemical shifts are reported in ppm, using external TMS (0 ppm) as reference. The 2D-TOCSY experiment (70 ms mixing time) was performed using a data matrix of 256 × 2K to digitize a spectral width of 3000 Hz. Four scans were used per increment with a relaxation delay of 2s. 2D-NOESY (600, 800 and 1000 ms) and 2D-T-ROESY experiments (300, 400 and 500 ms) used the standard sequences. 1D-Selective NOE spectra were acquired using the double echo sequence proposed by Shaka and co-workers at 250, 350, 450, and 550 ms of mixing time.35 Distances were estimated from NOESY/ROESY experimental data as follows NOE intensities were normalized with respect to the diagonal peak at zero mixing time. Selective Τ1 measurements were performed on the anomeric and several other protons to obtain the above-mentioned values. Experimental NOE's were fitted to a double exponential function, f(t) = p0(e−p1t)(1-e−p2t) with p0, p1 and p2 being adjustable parameters.12 The initial slope was determined from the first derivative at time t = 0, f′(0) = p0p2. From the initial slopes, inter-proton distances were obtained by employing the isolated spin pair approximation.

All the theoretical NOE calculations were automatically performed by a home-made programme, which is available from the authors upon request.33,34

Supplementary Material

01

Scheme 1.

Scheme 1

Retrosynthesis of the difluoromethylene linked C-disaccharide

Acknowledgment

This investigation was supported by grant R01 GM57865 from the National Institutes of Health (NIH). “Research Centers in Minority Institutions” award RR-03037 from the National Center for Research Resources of the NIH, which supports the infrastructure and instrumentation of the Chemistry Department at Hunter College is also acknowledged. The group at Madrid thanks the Ministery of Science of Education of Spain (grant CTQ2006-C02-01) for funding.

Footnotes

Supplementary data

Supplementary data associated with this article can be found, in the online version, at

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.(a) Postema MHD. C-Glycoside Synthesis. CRC Press; Boca Raton, Fl: 1995. For C-glycoside reviews. [Google Scholar]; (b) Levy DE, Tang C. The Synthesis of C-Glycosides. Oxford; Pergamon: 1995. [Google Scholar]; (c) Beau J-M, Gallagher T. Top. Curr. Chem. 1997;187:1–54. [Google Scholar]; (d) Togo H, He W, Waki Y, Yokoyama M. Synlett. 1998:700–717. [Google Scholar]; (e) Du Y, Linhardt RJ, Vlahov JR. Tetrahedron. 1998;54:9913–9959. [Google Scholar]; (f) Postema MHD, Piper JL, Betts RL. Synthesis. 2005:1345–1358. [Google Scholar]; (g) Yuan X, Linhardt RJ. Curr. Top. Med. Chem. 2005;5:1393–1430. doi: 10.2174/156802605774643033. [DOI] [PMC free article] [PubMed] [Google Scholar]; (h) Levy DE. In: The Organic Chemistry of Sugars. Levy DE, Fügedi P, editors. CRC Press / Taylor & Francis; Boca Raton: 2005. pp. 269–348. [Google Scholar]
  • 2.For examples of relative activity of O-glycosides and their exact C-glycoside analogues: Acton EM, Ryan KJ, Tracy M, Arora SK. Tetrahedron Lett. 1986;27:4245–4248.Wei A, Boy KM, Kishi Y. J. Am. Chem. Soc. 1995;117:9432–9436.Uchiyama T, Vassilev VP, Kajimoto T, Wong W, Huang H, Lin C-C, Wong C-H. J. Am. Chem. Soc. 1995;117:5395–5396. Xin Y-C, Zhang Y-M, Mallet J-M, Glaudemans CPJ, Sinaÿ P. Eur. J. Org. Chem. 1999:471–476. Link JT, Sorensen BK. Tetrahedron Lett. 2000;41:9213–9217. Mikkelsen LM, Hernáiz MJ, Martín-Pastor M, Skrydstrup T, Jiménez-Barbero J. J. Am. Chem. Soc. 2002;124:14940–14951. doi: 10.1021/ja020468x. Yang G, Schmieg J, Tsuji M, Franck RW. Angew. Chem. Int. Ed. 2004;43:3818–3822. doi: 10.1002/anie.200454215.
  • 3.Jiménez-Barbero J, Espinosa JF, Asensio JL, Cañada FJ, Poveda A. Adv. Carbohydr. Chem. Biochem. 2001;56:235–284. doi: 10.1016/s0065-2318(01)56006-0. [DOI] [PubMed] [Google Scholar]
  • 4.For an example where O- and C- glycosides bind in different conformations with respect to the intersaccharide torsions: Espinosa JF, Montero E, Vian A, García JL, Dietrich H, Schmidt RR, Martín-Lomas M, Imberty A, Cañada FJ, Jiménez-Barbero J. J. Am. Chem. Soc. 1998;120:1309–1318.
  • 5.(a) Gabius H-J. Pharm.. Res. 1998;15:23–30. doi: 10.1023/a:1011936300845. [DOI] [PubMed] [Google Scholar]; (b) Dam TK, Brewer CF. Chem. Rev. 2002;102:387–429. doi: 10.1021/cr000401x. [DOI] [PubMed] [Google Scholar]
  • 6.Tozer MJ, Herpin TF. Tetrahedron. 1996;52:8619–8683. [Google Scholar]
  • 7.The preferred gauche conformation in 2-fluoroethyl residues attached to electronegative substituents is well documented. For recent examples: Briggs CRS, O'Hagan D, Howard JAK, Yufit DS. J. Fluorine Chem. 2003;119:9–13. Briggs CRS, O'Hagan D, Rzepa HS, Slawin AMZ. J. Fluorine Chem. 2004;125:19–25.
  • 8.Meier C, Knispel T, Marquez VE, Siddiqui MA, De Clercq E, Balzarini J. J. Med. Chem. 1999;42:1615–1624. doi: 10.1021/jm981097r. [DOI] [PubMed] [Google Scholar]
  • 9.Burkholder CR, Dolbier WR, Jr., Médebielle M. J. Fluorine Chem. 2001;109:39–48. [Google Scholar]
  • 10.(a) Blackburn GM, Kent DE, Kolkmann F. J. Chem. Soc., Perkin Trans. I. 1984:1119–1125. [Google Scholar]; (b) Thatcher GRJ, Campbell AS. J. Org. Chem. 1993;58:2272–2281. [Google Scholar]; (c) Nieschalk J, O'Hagan D. J. Chem. Soc. Chem. Commun. 1995:719–720. [Google Scholar]
  • 11.For examples of difluoromethylene-linked C-furanosides: Herpin TF, Motherwell WB, Tozer MJ. Tetrahedron Asym. 1994;5:2269–2282. Herpin TF, Motherwell WB, Weibel J–M. J. Chem. Soc. Chem. Commun. 1997:923–924.
  • 12.(a) Asensio JL, Cañada FJ, Cheng X, Khan N, Mootoo DR, Jiménez-Barbero J. Chem. Eur. J. 2000;6:1035–1041. doi: 10.1002/(sici)1521-3765(20000317)6:6<1035::aid-chem1035>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]; (b) García-Aparicio V, Fernández-Alonso M, Angulo J, Asensio JL, Cañada FJ, Jiménez-Barbero J, Mootoo DR, Cheng X. Tetrahedron Asymmetry. 2005;16:519–527. [Google Scholar]
  • 13.Pérez-Castells J, Hernández-Gay JJ, Denton RW, Tony KA, Mootoo DR, Jiménez-Barbero JJ. Org. Biomol. Chem. 2007 doi: 10.1039/b615752a. DOI: 10.1039/B615752A. [DOI] [PubMed] [Google Scholar]
  • 14.(a) Hiruma K, Kajimoto T, Weitz-Schmidt G, Ollmann I, Wong C-H. J. Am. Chem. Soc. 1996;118:9265–9270. [Google Scholar]; (b) Hiruma K, Kanie O, Wong C-H. Tetrahedron. 1998;54:15781–15792. [Google Scholar]; (c) Shibata K, Hiruma K, Kanie O, Wong C-H. J. Org. Chem. 2000;65:2393–2398. doi: 10.1021/jo991556b. [DOI] [PubMed] [Google Scholar]
  • 15.For a preliminary account on the synthesis of 5 and related fluorinated β-C-galactosides: Tony KA, Denton RW, Dilhas A, Jiménez-Barbero J, Mootoo DR. Org. Lett. 2007;7 doi: 10.1021/ol070169i. DOI.
  • 16.(a) Khan N, Cheng X, Mootoo DR. J. Am. Chem. Soc. 1999;121:4918–4919. [Google Scholar]; (b) Cheng X, Khan N, Mootoo DR. J. Org. Chem. 2000;65:2544–2547. doi: 10.1021/jo991898h. [DOI] [PubMed] [Google Scholar]; (c) Denton RW, Cheng X, Tony KA, Dilhas A, Hernández JJ, Canales A, Jiménez-Barbero J, Mootoo DR. Eur. J. Org. Chem. 2007:645–654. [Google Scholar]
  • 17.(a) Middleton WJ, Bingham EM. J. Org. Chem. 1980;45:2883–2887. [Google Scholar]; (b) Hägele G, Haas A. J. Fluorine Chem. 1996;76:15–19. [Google Scholar]; (c) Dubowchik GM, Padilla L, Edinger K, Firestone RA. J. Org. Chem. 1996;61:4676–4684. doi: 10.1021/jo960367f. [DOI] [PubMed] [Google Scholar]
  • 18.(a) Matsumura Y, Asai T, Shimada T, Nakayama T, Urushihara M, Morizawa Y, Yasuda A, Yamamoto T, Fujitani B, Hosoki K. Chem. Pharm. Bull. 1995;43:353–355. doi: 10.1248/cpb.43.353. [DOI] [PubMed] [Google Scholar]; (b) Chang CS, Negishi M, Nakano T, Morizawa Y, Matsumura Y, Ichikawa A. Prostaglandins. 1997;53:83–90. doi: 10.1016/s0090-6980(97)00003-8. [DOI] [PubMed] [Google Scholar]
  • 19.For the same reaction on related aldehydes: Marcotte S, D'Hooge F, Ramadas S, Feasson C, Pannecoucke X, Quirion J-C. Tetrahedron Lett. 2001;42:5879–5882. Li Y, Drew MGB, Welchman EV, Shirastava RK, Jiang S, Valentine R, Singh G. Tetrahedron. 2004;60:6523–6531. Karche NP, Pierry C, Poulain F, Oulyadi H, Leclerc E, Pannecoucke X, Quirion J-C. Synlett. 2007:123–126.
  • 20.For aldehyde 11: Skaanderup PR, Hyldtoft L, Madsen R. Monatsh. Chem. 2002;133:467–472.
  • 21.(a) Inanaga J, Hirata K, Saeki H, Katsuki T, Yamaguchi M. Bull. Chem. Soc. Jpn. 1979;52:1989–1993. [Google Scholar]; (b) White JD, Blakemore PR, Browder CC, Hong J, Lincoln CM, Nagornyy PA, Robarge LA, Wardrop DJ. J. Am. Chem. Soc. 2001;123:8593–8595. doi: 10.1021/ja011256n. [DOI] [PubMed] [Google Scholar]
  • 22.(a) Takai K, Kakiuchi T, Kataoka Y, Utimoto K. J. Org. Chem. 1994;59:2668–2670. [Google Scholar]; (b) Postema MHD, Calimente D, Liu L, Behrmann TL. J. Org. Chem. 2000;65:6061–6068. doi: 10.1021/jo0005159. [DOI] [PubMed] [Google Scholar]
  • 23.(a) Pearlman DA, Case DA, Caldwell JW, Ross WS, Cheatham TE, DeBolt S, Ferguson D, Siebal G, Kollmann PA. Comput. Phys. Commun. 1995;91:1–41. [Google Scholar]; (b) Allinger NL, Yuh YH, Lii JH. J. Am. Chem. Soc. 1989;111:8551–8566. [Google Scholar]
  • 24.Asensio JL, Espinosa JF, Dietrich H, Cañada FJ, Schmidt RR, Martin-Lomas M, André S, Gabius H-J, Jiménez-Barbero J. J. Am. Chem. Soc. 1999;121:8995–9000. [Google Scholar]
  • 25.(a) Poveda A, Asensio JL, Polat T, Bazin H, Linhardt RJ, Jiménez-Barbero J. Eur. J. Org. Chem. 2000:1805–1813. [Google Scholar]; (b) Montero E, García-Herrero A, Asensio JL, Hirai K, Ogawa S, Santoyo-González F, Cañada F,FJ, Jiménez-Barbero J. Eur. J. Org. Chem. 2000:1945–1952. and references cited therein. [Google Scholar]
  • 26.For a discussion on the application of molecular mechanics force fields to sugar molecules, see: Perez S, Imberty A, Engelsen S, Gruza J, Mazeau K, Jimenez-Barbero J, Poveda A, Espinosa JF, van Eyck BP, Johnson G. Carbohydr. Res. 1998;314:141–155.
  • 27.Neuhaus D, Williamson MP. The Nuclear Overhauser Effect in Structural and Conformational Analysis. VCH; New York: 1989. [Google Scholar]
  • 28.Bock K, Duus JO. J. Carbohydr. Chem. 1994;13:513–543. [Google Scholar]
  • 29.Haasnoot CAG, de Leeuw FAAM, Altona C. Tetrahedron. 1980;36:2783–2794. [Google Scholar]
  • 30.(a) Thibaudeau C, Plavec J, Chattopadhyaya J. J. Org. Chem. 1998;67:4967–4984. [Google Scholar]; (b) Karplus M. J. Chem. Phys. 1959;30:11–15. [Google Scholar]
  • 31.(a) Velter I, Nicotra F, Laferla B, Bernardi A, Marcou G, Motto I, Mari S, Cañada FJ, Jimenez-Barbero J. Eur. J. Org. Chem. 2006:2925–2933. [Google Scholar]; (b) Mari S, Sánchez-Medina I, Jimenez-Barbero J, Bernardi A. Carbohydr Res. 2007 doi: 10.1016/j.carres.2007.03.019. in press, accompanying paper in this issue. [DOI] [PubMed] [Google Scholar]
  • 32.Mohamadi F, Richards NGJ, Guida WC, Liskamp R, Caufield C, Chang G, Hendrickson T, Still WC. J. Comput. Chem. 1990;11:440–467. [Google Scholar]
  • 33.Espinosa JF, Martín-Pastor M, Asensio JL, Dietrich H, Martín-Lomas M, Schmidt RR, Jiménez-Barbero J. Tetrahedron Lett. 1995;36:6329–6332. [Google Scholar]
  • 34.Asensio JL, Martín-Pastor M, Jiménez-Barbero J. Int. J. Biol. Macromol. 1995;17:137–148. doi: 10.1016/0141-8130(95)92680-o. [DOI] [PubMed] [Google Scholar]
  • 35.Stott K, Stonehouse J, Keeler J, Hwang TL, Shaka AJ. J. Am. Chem. Soc. 1995;117:4199–4200. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

01

RESOURCES